IDIQ to Support the Advisory Committee on Heritable Disorders in Newborns and Children

The Health Resources and Services Administration (HRSA) Office of Operations issued solicitation 75R60220R00023 to establish an Indefinite Delivery, Indefinite Quantity (IDIQ) contract supporting the Advisory Committee on Heritable Disorders in Newborns and Children. The primary purpose of this requirement is to provide the Secretary of Health and Human Services with technical information, advice, and recommendations to reduce morbidity and mortality in children at risk for heritable disorders. The committee focuses on enhancing the capacity of state and local health agencies to deliver screening, counseling, and healthcare services while providing systematic, evidence-based recommendations on conditions for the Recommended Uniform Screening Panel.

The procurement is classified under NAICS 541720 for Research and Development in the Social Sciences and Humanities and PSC B537 for Special Studies/Analysis- Medical/Health. Work performed under this contract involves analyzing technologies, policies, and standards related to newborn screening methods that have a significant impact on public health. The initial notice was published on July 30, 2020, and the response deadline for interested parties was August 24, 2020.

Biji John serves as the point of contact for this federal opportunity. The solicitation includes 14 attachments, including revised Statement of Work documents, technical sections A through J, and official question and answer sets. The notice was last updated on January 6, 2021, and the solicitation is overseen by the HRSA Office of Operations.